Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
partnership
Biotech
GSK initiates breakup with Ideaya, hands back 2 programs
GSK is walking away from Ideaya after a five-year-long partnership that initially covered three of Ideaya's synthetic lethality programs.
Zoey Becker
Dec 9, 2025 7:15am
Enable Injections, Incyte ink drug delivery collab
Oct 29, 2025 10:15am
Evoq Therapeutics signs on with Sanofi in $500M partnership
Oct 16, 2025 10:25am
Erasca looks to partner off late-stage melanoma asset
May 13, 2025 10:38am
BioAge secures Novartis deal worth up to $550M biobucks
Dec 18, 2024 10:44am
Acepodia, Pfizer click together for chemistry-based cell therapy
Sep 3, 2024 5:00pm